Susan Hasty, Publisher
Table of Contents . . . May 14th, 2010
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Lab Law Weekly | Other Publications
Biotechnology - 2010 BIO International Convention Highlights Key Policy Issues For Biotechnology
BioScrip, Inc. - BioScrip, Inc. Reports 2010 First Quarter Results
CIGNA - CIGNA to Implement Federal Rescission Reforms on May 1
Medicare and Medicaid - DaVita 1st Quarter 2010 Results
Mental Retardation - Department of Public Welfare Discriminates Against Deaf Pennsylvanians with Intellectual Disabilities
Medicare and Medicaid - Detroit-Area Doctor Sentenced to 72 Months in Prison for Medicare Fraud Scheme
Stipkala Llc - Dr. Jeremy M. Stipkala, Patent Attorney, Speaks on USC NanoCenter Panel
Health Information Technology - Fox Systems to Conduct Alaska State Medicaid Health Information Technology Plan SMHP Technical Assistance
Freedland Russo - Freedland Russo Announces $520 Million Settlement Against AstraZeneca
Holzer Holzer & Fistel, LLC - Holzer Holzer & Fistel, LLC is Investigating Potential Violations of Federal Securities Laws by Xenoport, Inc.
Patents - INTUNIV - Shire Files Suit Against Teva
Dosage Forms - Impax Laboratories Confirms Patent Challenge Relating to Fenoglide(R) 40 and 120 mg Tablets
Critical Care Medicine - Instrumentation Laboratory Launches ACL Top 700 and ACL Top 700 CTS Hemostasis Testing Systems
Regenerative Medicine - Kinetic Concepts Reports First Quarter 2010 Financial Results
Electronic Medical Records - Medical & Surgical Clinic of Irving, Texas Selects Allscripts for Electronic Health Record
Hepatocellular Cancer - MultiCell Technologies Is Granted European Patent for the Treatment of Cancer
Group Net LLC - New York City Prescription Program Calls on City Health Care Providers to Help Distribute Free Repeating Discount Medication Coupon Cards
Multiple Sclerosis - Opexa Strengthens Management Team with Hire of Cell Therapy Expert
Topamax Therapy - Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax False Claims Lawsuit
Topamax Therapy - Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX Marketing and Promotional Activities
Regulatory Agencies - Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing
Managed Care - Prescription Drug Pricing Made Easy for Seniors
Saba - Public Sector Organizations around the World Turn to Saba for Strategic People Management
U.S. Food and Drug Administration - Repros Receives Guidance From FDA Regarding Clinical Hold Status of Proellex(R)
Medicare and Medicaid - Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs
Phenylacetates - Shire Receives INTUNIV Paragraph IV Notice Letter
Pediatric Research - The Children's Hospital of Philadelphia Joins Aetna Better Health Network
Medicare and Medicaid - Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
HIV/AIDS - Victory! AHF Lauds Merck for Doubling ADAP AIDS Drug Rebates for Isentress
Dosage Forms - Watson Confirms Rapamune Patent Challenge
Generics - Watson Says Appeals Court Affirms Concerta Patent Invalid
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.